Naloxone Hydrochloride
Product Images NDC 71288-814

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 71288-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Naloxone Hydrochloride Injection, USP Blister Package Label)

This text is a pharmaceutical label for a medication with NDC 71288-814-80 for intravenous, intramuscular, or subcutaneous use. It is manufactured by Meitheal Pharmaceuticals in Canada. The medication is to be stored at 20° to 25°C, protected from light, and is a 1 mL single-dose prefilled syringe. Additionally, it includes a tamper-evident cover and advises to discard any unused portion.*

FDA Label Image

Principal Display Panel (Naloxone Hydrochloride Injection, USP Carton)

FDA Label Image

Principal Display Panel (Naloxone Hydrochloride Injection, USP Syringe Label)

This is a product label for Naloxone Hydrochloride Injection, USP manufactured by Meitheal Pharmaceuticals. It is intended for use via intravenous, intramuscular, or subcutaneous administration and should be protected from light. The label contains the National Drug Code (NDC) 71288-814-80 and the prescription-only status of the medication. The volume provided is 0.5 mL.*

FDA Label Image

Structure (Naloxone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.